An evaluation of the evidence that methamphetamine abuse causes cognitive decline in humans

Neuropsychopharmacology

Volumn 38, Issue 2, 2013, Pages 259-274

  Dean, Andy C ^a   Groman, Stephanie M ^a   Morales, Angelica M ^a   London, Edythe D ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cognition; cognitive; methamphetamine; neuropsychology; review; stimulant

Indexed keywords

METHAMPHETAMINE;

BRAIN METABOLISM; BRAIN SIZE; CINGULATE GYRUS; COGNITION; COGNITIVE DEFECT; COGNITIVE RESERVE; DEMETHYLATION; DISEASE SEVERITY; DRUG REEXPOSURE; DRUG WITHDRAWAL; EXECUTIVE FUNCTION; GENETIC VARIABILITY; GLUCOSE METABOLISM; GRAY MATTER; HUMAN; INFERIOR FRONTAL GYRUS; INSULA; LEARNING; LEARNING DISORDER; META ANALYSIS (TOPIC); METHAMPHETAMINE DEPENDENCE; MIDDLE FRONTAL GYRUS; NERVE CELL PLASTICITY; NONHUMAN; OCCIPITAL CORTEX; ORBITAL CORTEX; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; REACTION TIME; READING; REFRACTORY PERIOD; REVIEW; TWINS; VERBAL MEMORY; VISUAL MEMORY; WORKING MEMORY;

AMPHETAMINE-RELATED DISORDERS; ANIMALS; COGNITION DISORDERS; HUMANS; METHAMPHETAMINE;

EID: 84871460593     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2012.179     Document Type: Review

References (129)

1. Acevedo SF, de Esch IJ, Raber J (2007). Sex-and histamine-dependent long-term cognitive effects of methamphetamine exposure. Neuropsychopharmacology 32: 665-672.
2. Anglin MD, Kalechstein AD, Maglione M, Annon J, Fiorentine R (1997). Methamphetmaine Abuse and Treatment in California: A Regional Report. University of California: Los Angeles.
3. Arai S, Takuma K, Mizoguchi H, Ibi D, Nagai T, Kamei H et al (2009). GABAB receptor agonist baclofen improves metham-phetamine-induced cognitive deficit in mice. Eur J Pharmacol 602: 101-104.
4. Baker A, Lee NK, Claire M, Lewin TJ, Grant T, Pohlman S et al (2005). Brief cognitive behavioural interventions for regular amphetamine users: a step in the right direction. Addiction 100: 367-378.
5. Barnett JH, Salmond CH, Jones PB, Sahakian BJ (2006). Cognitive reserve in neuropsychiatry. Psychol Med 36: 1053-1064.
6. Basso MR, Bornstein RA, Lang JM (1999). Practice effects on commonly used measures of executive function across twelve months. Clin Neuropsychol 13: 283-292.
7. Beglinger LJ, Gaydos B, Tangphao-Daniels O, Duff K, Kareken DA, Crawford J et al (2005). Practice effects and the use of alternate forms in serial neuropsychological testing. Arch Clin Neuropsy-chol 20: 517-529.
8. Belcher AM, Feinstein EM, O'Dell SJ, Marshall JF (2008). Methamphetamine influences on recognition memory: comparison of escalating and single-day dosing regimens. Neuropsycho-pharmacology 33: 1453-1463.
9. Belcher AM, O'Dell SJ, Marshall JF (2005). Impaired object recognition memory following methamphetamine, but not p-chloroamphetamine-or d-amphetamine-induced neurotoxi-city. Neuropsychopharmacology 30: 2026-2034.
10. Berman S, O'Neill J, Fears S, Bartzokis G, London ED (2008). Abuse of amphetamines and structural abnormalities in the brain. Ann N Y Acad Sci 1141: 195-220.
11. Berman SM, Voytek B, Mandelkern MA, Hassid BD, Isaacson A, Monterosso J et al (2007). Changes in cerebral glucose metabolism during early abstinence from chronic methamphe-tamine abuse. Mol Psychiatry 13: 897-908.
12. Bouchard TJ Jr (1998). Genetic and environmental influences on adult intelligence and special mental abilities. Hum Biol 70: 257-279.
13. Bowyer JF, Gough B, Slikker W Jr., Lipe GW, Newport GD, Holson RR (1993). Effects of a cold environment or age on metham-phetamine-induced dopamine release in the caudate putamen of female rats. Pharmacol Biochem Behav 44: 87-98.
14. Buffum JC, Shulgin AT (2001). Overdose of 2.3 grams of intravenous methamphetamine: case, analysis and patient perspective. J Psychoactive Drugs 33: 409-412.
15. Caldwell J, Dring LG, Williams RT (1972). Metabolism of [14 C]methamphetamine in man, the guinea pig, and the rat. Biochem J 129: 11-22.
16. Chang L, Alicata D, Ernst T, Volkow N (2007). Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction 102(Suppl 1): 16-32.
17. Chang L, Cloak C, Patterson K, Grob C, Miller EN, Ernst T (2005). Enlarged striatum in abstinent methamphetamine abusers: a possible compensatory response. Biol Psychiatry 57: 967-974.
18. Chang L, Ernst T, Speck O, Patel H, DeSilva M, Leonido-Yee M et al (2002). Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users. Psychiatry Res: Neuroimaging 114: 65-79.
19. Chapman DE, Hanson GR, Kesner RP, Keefe KA (2001). Long-term changes in basal ganglia function after a neurotoxic regimen of methamphetamine. J Pharmacol Exp Ther 296: 520-527.
20. Cherner M, Bousman C, Everall I, Barron D, Letendre S, Vaida F et al (2010a). Cytochrome P450-2D6 extensive metabolizers are more vulnerable to methamphetamine-associated neurocogni-tive impairment: preliminary findings. J Int Neuropsychol Soc 16: 890-901.
21. Cherner M, Suarez P, Casey C, Deiss R, Letendre S, Marcotte T et al (2010b). Methamphetamine use parameters do not predict neuropsychological impairment in currently abstinent dependent adults. Drug Alcohol Depend 106: 154-163.
22. Chou YH, Huang WS, Su TP, Lu RB, Wan FJ, Fu YK (2007). Dopamine transporters and cognitive function in methamphe-tamine abuser after a short abstinence: a SPECT study. Eur Neuropsychopharmacol 17: 46-52.
23. Clark RE, Kuczenski R, Segal DS (2007). Escalating dose, multiple binge methamphetamine regimen does not impair recognition memory in rats. Synapse 61: 515-522.
24. Daberkow DP, Kesner RP, Keefe KA (2005). Relation between methamphetamine-induced monoamine depletions in the stria-tum and sequential motor learning. Pharmacol Biochem Behav 81: 198-204.
25. Dalley JW, Laane K, Theobald DE, Pena Y, Bruce CC, Huszar AC et al (2007). Enduring deficits in sustained visual attention during withdrawal of intravenous methylenedioxymethamphe-tamine self-administration in rats: results from a comparative study with d-amphetamine and methamphetamine. Neuropsy-chopharmacology 32: 1195-1206.
26. Dean AC, Hellemann G, Sugar CA, London ED (2012). Educational attainment is not a good proxy for cognitive function in methamphetamine dependence. Drug Alcohol Depend 123: 249-254.
27. Dean AC, London ED (2010). Cerebral deficits associated with impaired cognition and regulation of emotion in methamphe-tamine abuse. In: Kassel JD (ed) Substance Abuse and Emotion. American Psychological Association: Washington, D.C., pp 237-257.
28. Dikmen SS, Heaton RK, Grant I, Temkin NR (1999). Test-retest reliability and practice effects of expanded Halstead-Reitan Neuropsychological Test Battery. J Int Neuropsychol Soc 5: 346-356.
29. Dowling GJ, Weiss SR, Condon TP (2008). Drugs of abuse and the aging brain. Neuropsychopharmacology 33: 209-218.
30. Elkashef A, Vocci F, Hanson G, White J, Wickes W, Tiihonen J (2008). Pharmacotherapy of methamphetamine addiction: an update. Subst Abus 29: 31-49.
31. Elkins JS, Longstreth WT Jr, Manolio TA, Newman AB, Bhadelia RA, Johnston SC (2006). Education and the cognitive decline associated with MRI-defined brain infarct. Neurology 67: 435-440.
32. Ersche KD, Jones PS, Williams GB, Turton AJ, Robbins TW, Bullmore ET (2012). Abnormal brain structure implicated in stimulant drug addiction. Science 335: 601-604.
33. Fein G, Di Sclafani V (2004). Cerebral reserve capacity: implications for alcohol and drug abuse. Alcohol 32: 63-67.
34. First MB, Spitzer RL, Gibbon M, Williams J (1996). Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition (SCID-IP, Version 2.0). Biometrics Research Department, New York State Psychiatric Institute: New York, NY.
35. Gonzalez R, Rippeth JD, Carey CL, Heaton RK, Moore DJ, Schweinsburg BC et al (2004). Neurocognitive performance of methamphetamine users discordant for history of marijuana exposure. Drug Alcohol Depend 76: 181-190.
36. Grace CE, Schaefer TL, Herring NR, Graham DL, Skelton MR, Gudelsky GA et al (2010). Effect of a neurotoxic dose regimen of (\+)-methamphetamine on behavior, plasma corticosterone, and brain monoamines in adult C57BL/6 mice. Neurotoxicol Teratol 32: 346-355.
37. Groman SM, Lee B, Seu E, James AS, Feiler K, Mandelkern MA et al (2012). Dysregulation of d2-mediated dopamine transmission in monkeys after chronic escalating methamphetamine exposure. J Neurosci 32: 5843-5852.
38. Hart CL, Gunderson EW, Perez A, Kirkpatrick MG, Thurmond A, Comer SD et al (2008). Acute physiological and behavioral effects of intranasal methamphetamine in humans. Neuropsy-chopharmacology 33: 1847-1855.
39. Hart CL, Marvin CB, Silver R, Smith EE (2011). Is cognitive functioning impaired in methamphetamine users? A critical review. Neuropsychopharmacology 37: 586-608.
40. Heaton RK, Ryan L, Grant I, Matthews CG (1996). Demographic influences on neuropsychological test performance. In: Grant IAdams KM (eds). Neuropsychological Assessment of Neuropsychiatric Disorders. 2nd edn. Oxford University Press: New York, pp 141-163.
41. Henry BL, Minassian A, Perry W (2010). Effect of methampheta-mine dependence on everyday functional ability. Addict Behav 35: 593-598.
42. Henry JD, Mazur M, Rendell PG (2009). Social-cognitive difficulties in former users of methamphetamine. Br J Clin Psychol 48(Part 3): 323-327.
43. Herring NR, Schaefer TL, Gudelsky GA, Vorhees CV, Williams MT (2008). Effect of\+-methamphetamine on path integration learning, novel object recognition, and neurotoxicity in rats. Psychopharmacology (Berl) 199: 637-650.
44. Hillhouse MP, Marinelli-Casey P, Gonzales R, Ang A, Rawson RA (2007). Predicting in-treatment performance and post-treatment outcomes in methamphetamine users. Addiction 102(Suppl 1): 84-95.
45. Hoffman WF, Moore M, Templin R, McFarland B, Hitzemann RJ, Mitchell SH (2006). Neuropsychological function and delay discounting in methamphetamine-dependent individuals. Psy-chopharmacology (Berl) 188: 162-170.
46. Hukkelhoven CW, Steyerberg EW, Rampen AJ, Farace E, Habbema JD, Marshall LF et al (2003). Patient age and outcome following severe traumatic brain injury: an analysis of 5600 patients. J Neurosurg 99: 666-673.
47. Ito Y, Takuma K, Mizoguchi H, Nagai T, Yamada K (2007). A novel azaindolizinone derivative ZSET1446 (spiro[imidazo[1,2-a] pyridine-3,2-indan]- 2(3H)-one) improves methamphetamine-induced impairment of recognition memory in mice by activating extracellular signal-regulated kinase 1/2. J Pharmacol Exp Ther 320: 819-827.
48. Iudicello JE, Weber E, Grant I, Weinborn M, Woods SP (2011). Misremembering future intentions in methamphetamine-depen-dent individuals. Clin Neuropsychol 25: 269-286.
49. Iudicello JE, Woods SP, Vigil O, Scott JC, Cherner M, Heaton RK et al (2010). Longer term improvement in neurocognitive functioning and affective distress among methamphetamine users who achieve stable abstinence. J Clin Exp Neuropsychol 32: 704-718.
50. Izquierdo A, Belcher AM, Scott L, Cazares VA, Chen J, O'Dell SJ et al (2010). Reversal-specific learning impairments after a binge regimen of methamphetamine in rats: possible involvement of striatal dopamine. Neuropsychopharmacology 35: 505-514.
51. Jaffe C, Bush KR, Straits-Troster K, Meredith C, Romwall L, Rosenbaum G et al (2005). A comparison of methamphetamine-dependent inpatients with and without childhood attention deficit hyperactivity disorder symptomatology. J Addict Dis 24: 133-152.
52. Johanson CE, Frey KA, Lundahl LH, Keenan P, Lockhart N, Roll J et al (2006). Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers. Psychopharmacology (Berl) 185: 327-338.
53. Jones RN, Yang FM, Zhang Y, Kiely DK, Marcantonio ER, Inouye SK (2006). Does educational attainment contribute to risk for delirium? A potential role for cognitive reserve. J Gerontol A Biol Sci Med Sci 61: 1307-1311.
54. Kalechstein AD, Newton TF, Green M (2003). Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence. Neurophysiology Clin 15: 215-220.
55. Kamei H, Nagai T, Nakano H, Togan Y, Takayanagi M, Takahashi K et al (2006). Repeated methamphetamine treatment impairs recognition memory through a failure of novelty-induced ERK1/2 activation in the prefrontal cortex of mice. Biol Psychiatry 59: 75-84.
56. Kesler SR, Adams HF, Blasey CM, Bigler ED (2003). Premorbid intellectual functioning, education, and brain size in traumatic brain injury: an investigation of the cognitive reserve hypothesis. Appl Neuropsychol 10: 153-162.
57. Kim SJ, Lyoo IK, Hwang J, Chung A, Hoon SY, Kim J et al (2006). Prefrontal grey-matter changes in short-term and long-term abstinent methamphetamine abusers. Int J Neuropsychopharma-col 9: 221-228.
58. King G, Alicata D, Cloak C, Chang L (2010). Neuropsychological deficits in adolescent methamphetamine abusers. Psychophar-macology (Berl) 212: 243-249.
59. Kosheleff AR, Grimes M, O'Dell SJ, Marshall JF, Izquierdo A (2012). Work aversion and associated changes in dopamine and serotonin transporter after methamphetamine exposure in rats. Psychopharmacology (Berl) 219: 411-420.
60. Kramer JC, Fischman VS, Littlefield DC (1967). Amphetamine abuse. Pattern and effects of high doses taken intravenously. JAMA 201: 305-309.
61. Kulig BM, Calhoun WH (1972). Enhancement of successive discrimination reversal learning by methamphetamine. Psycho-pharmacologia 27: 233-240.
62. Lanzino G, Kassell NF, Germanson TP, Kongable GL, Truskowski LL, Torner JC et al (1996). Age and outcome after aneurysmal subarachnoid hemorrhage: why do older patients fare worse? J Neurosurg 85: 410-418.
63. Lee KW, Kim HC, Lee SY, Jang CG (2011). Methamphetamine-sensitized mice are accompanied by memory impairment and reduction of N-methyl-d-aspartate receptor ligand binding in the prefrontal cortex and hippocampus. Neuroscience 178: 101-107.
64. Leland DS, Arce E, Miller DA, Paulus MP (2008). Anterior cingulate cortex and benefit of predictive cueing on response inhibition in stimulant dependent individuals. Biol Psychiatry 63: 184-190.
65. Lezak MD, Howieson DB, Loring DW (eds) (2004). Neuropsycho-logical Assessment. Oxford University Press: Oxford.
66. Lu P, Mamiya T, Lu L, Mouri A, Niwa M, Kim HC et al (2010). Silibinin attenuates cognitive deficits and decreases of dopamine and serotonin induced by repeated methamphetamine treatment. Behav Brain Res 207: 387-393.
67. Luerssen TG, Klauber MR, Marshall LF (1988). Outcome from head injury related to patient's age. A longitudinal prospective study of adult and pediatric head injury. J Neurosurg 68: 409-416.
68. Mahoney JJ III, Jackson BJ, Kalechstein AD, De la Garza R II, Newton TF (2011). Acute, low-dose methamphetamine administration improves attention/information processing speed and working memory in methamphetamine-dependent individuals displaying poorer cognitive performance at baseline. Prog Neuropsychopharmacol Biol Psychiatry 35: 459-465.
69. Marcotte TD, Grant I (eds) (2010). Neuropsychology of Everyday Function. Guilford Press: New York.
70. McDowell I, Xi G, Lindsay J, Tierney M (2007). Mapping the connections between education and dementia. J Clin Exp Neuropsychol 29: 127-141.
71. McKetin R, Mattick RP (1998). Attention and memory in illicit amphetamine users: comparison with non-drug-using controls. Drug Alcohol Depend 50: 181-184.
72. McKetin R, Ross J, Kelly E, Baker A, Lee N, Lubman DI et al (2008). Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants. Drug Alcohol Rev 27: 277-285.
73. Meyer JH, Goulding VS, Wilson AA, Hussey D, Christensen BK, Houle S (2002). Bupropion occupancy of the dopamine transporter is low during clinical treatment. Psychopharmacol-ogy (Berl) 163: 102-105.
74. Miller RG (1981). Simultaneous Statistical Inference. 2nd edn. Springer-Verlag Inc.: New York.
75. Mitrushina M Boone B Razani J D'Elia LF (eds) (2005). Handbook of Normative Data for Neuropsychological Assessment. Oxford University Press: Oxford.
76. Mizoguchi H, Ibi D, Takase F, Nagai T, Kamei H, Toth E et al (2011). Nicotine ameliorates impairment of working memory in methamphetamine-treated rats. Behav Brain Res 220: 159-163.
77. Monterosso JR, Aron AR, Cordova X, Xu J, London ED (2005). Deficits in response inhibition associated with chronic metham-phetamine abuse. Drug Alcohol Depend 79: 273-277.
78. Morales AM, Lee B, Hellemann G, O'Neill J, London ED (2012). Gray matter volume in methamphetamine dependence: cigarette smoking and changes with abstinence from methamphetamine. Drug Alcohol Depend; e-pub ahead of print 22 March 2012.
79. Nagai T, Takuma K, Dohniwa M, Ibi D, Mizoguchi H, Kamei H et al (2007). Repeated methamphetamine treatment impairs spatial working memory in rats: reversal by clozapine but not haloperidol. Psychopharmacology (Berl) 194: 21-32.
80. Noda Y, Mouri A, Ando Y, Waki Y, Yamada SN, Yoshimi A et al (2010). Galantamine ameliorates the impairment of recognition memory in mice repeatedly treated with methamphetamine: involvement of allosteric potentiation of nicotinic acetylcholine receptors and dopaminergic-ERK1/2 systems. Int J Neuro-psychopharmacol 13: 1343-1354.
81. Nurmi E, Bergman J, Eskola O, Solin O, Hinkka SM, Sonninen P et al (2000). Reproducibility and effect of levodopa on dopamine transporter function measurements: a [18F]CFT PET study. J Cereb Blood Flow Metab 20: 1604-1609.
82. O'Dell SJ, Feinberg LM, Marshall JF (2011). A neurotoxic regimen of methamphetamine impairs novelty recognition as measured by a social odor-based task. Behav Brain Res 216: 396-401.
83. Ogden CL, Fryar CD, Carroll MD, Flegal KM (2004). Mean body weight, height, and body mass index, United States 1960-2002. Adv Data 347: 1-17.
84. Parsegian A, Glen WB Jr, Lavin A, See RE (2011). Methampheta-mine self-administration produces attentional set-shifting deficits and alters prefrontal cortical neurophysiology in rats. Biol Psychiatry 69: 253-259.
85. Payer DE, Dean AC, Boileau I (2012). What matters in measuring methamphetamine-related cognitive impairments: 'abnormality detection' versus 'everyday import'? Neuropsychopharmacology 37: 1081-1082.
86. Price KL, DeSantis SM, Simpson AN, Tolliver BK, McRae-Clark AL, Saladin ME et al (2011). The impact of clinical and demographic variables on cognitive performance in metham-phetamine-dependent individuals in rural South Carolina. Am J Addict 20: 447-455.
87. Rawson RA, Condon TP (2007). Why do we need an addiction supplement focused on methamphetamine? Addiction 102(Suppl 1): 1-4.
88. Rawson RA, Marinelli-Casey P, Anglin MD, Dickow A, Frazier Y, Gallagher C et al (2004). A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence. Addiction 99: 708-717.
89. Reichel CM, Schwendt M, McGinty JF, Olive MF, See RE (2011). Loss of object recognition memory produced by extended access to methamphetamine self-administration is reversed by positive allosteric modulation of metabotropic glutamate receptor 5. Neuropsychopharmacology 36: 782-792.
90. Rendell PG, Mazur M, Henry JD (2009). Prospective memory impairment in former users of methamphetamine. Psychophar-macology (Berl) 203: 609-616.
91. Richards JB, Sabol KE, de Wit H (1999). Effects of metham-phetamine on the adjusting amount procedure, a model of impulsive behavior in rats. Psychopharmacology (Berl) 146: 432-439.
92. Rippeth JD, Heaton RK, Carey CL, Marcotte TD, Moore DJ, Gonzalez R et al (2004). Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. J Int Neuropsychol Soc 10: 1-14.
93. Rogers JL, De Santis S, See RE (2008). Extended methamphetamine self-administration enhances reinstatement of drug seeking and impairs novel object recognition in rats. Psychopharmacology (Berl) 199: 615-624.
94. Rourke SB, Grant I (1999). The interactive effects of age and length of abstinence on the recovery of neuropsychological functioning in chronic male alcoholics: a 2-year follow-up study. J Int Neuropsychol Soc 5: 234-246.
95. Salo R, Fassbender C (2012). Structural, functional and spectro-scopic MRI studies of methamphetamine addiction. Curr Top Behav Neurosci 11: 321-364.
96. Salo R, Gabay S, Fassbender C, Henik A (2011). Distributed atten-tional deficits in chronic methamphetamine abusers: evidence from the Attentional Network Task (ANT). Brain Cogn 77: 446-452.
97. Salo R, Nordahl TE, Galloway GP, Moore CD, Waters C, Leamon MH (2009). Drug abstinence and cognitive control in methampheta-mine-dependent individuals. J Subst Abuse Treat 37: 292-297.
98. Salo R, Nordahl TE, Moore C, Waters C, Natsuaki Y, Galloway GP et al (2005). A dissociation in attentional control: evidence from methamphetamine dependence. Biol Psychiatry 57: 310-313.
99. Salo R, Nordahl TE, Natsuaki Y, Leamon MH, Galloway GP, Waters C et al (2007). Attentional control and brain metabolite levels in methamphetamine abusers. Biol Psychiatry 61: 1272-1280.
100. SAMHSA (2009). Results from the 2008 National Survey on Drug Use and Health: National Findings. Office of Applied Studies: Rockville, MD.
101. Satz P (1993). Brain reserve and capacity on symptom onset after brain injury: a formulation and review of evidence for threshold theory. Neuropsychology 7: 273-295.
102. Schottenbauer MA, Momenan R, Kerick M, Hommer DW (2007). Relationships among aging, IQ, and intracranial volume in alcoholics and control subjects. Neuropsychology 21: 337-345.
103. Scott JC, Woods SP, Matt GE, Meyer RA, Heaton RK, Atkinson JH et al (2007). Neurocognitive effects of methamphetamine: a critical review and meta-analysis. Neuropsychol Rev 17: 275-297.
104. Segal DS, Kuczenski R, O'Neil ML, Melega WP, Cho AK (2003). Escalating dose methamphetamine pretreatment alters the behavioral and neurochemical profiles associated with exposure to a high-dose methamphetamine binge. Neuropsychopharma-cology 28: 1730-1740.
105. Shoblock JR, Maisonneuve IM, Glick SD (2003). Differences between d-methamphetamine and d-amphetamine in rats: working memory, tolerance, and extinction. Psychopharmacol-ogy (Berl) 170: 150-156.
106. Shoptaw S, Heinzerling KG, Rotheram-Fuller E, Steward T, Wang J, Swanson AN et al (2008). Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence. Drug Alcohol Depend 96: 222-232.
107. Siegel JA, Craytor MJ, Raber J (2010). Long-term effects of methamphetamine exposure on cognitive function and muscari-nic acetylcholine receptor levels in mice. Behav Pharmacol 21: 602-614.
108. Silverberg ND, Millis SR (2009). Impairment versus deficiency in neuropsychological assessment: implications for ecological validity. J Int Neuropsychol Soc 15: 94-102.
109. Simoes PF, Silva AP, Pereira FC, Marques E, Grade S, Milhazes N et al (2007). Methamphetamine induces alterations on hippo-campal NMDA and AMPA receptor subunit levels and impairs spatial working memory. Neuroscience 150: 433-441.
110. Simon SL, Dacey J, Glynn S, Rawson R, Ling W (2004). The effect of relapse on cognition in abstinent methamphetamine abusers. J Subst Abuse Treat 27: 59-66.
111. Simon SL, Dean AC, Cordova X, Monterosso JR, London ED (2010). Methamphetamine dependence and neuropsychological functioning: evaluating change during early abstinence. J Stud Alcohol Drugs 71: 335-344.
112. Simon SL, Domier C, Carnell J, Brethen P, Rawson R, Ling W (2000). Cognitive impairment in individuals currently using methamphetamine. Am J Addict 9: 222-231.
113. Simon SL, Richardson K, Dacey J, Glynn S, Domier CP, Rawson RA et al (2002). A comparison of patterns of methamphetamine and cocaine use. J Addict Dis 21: 35-44.
114. Sommers I, Baskin D, Baskin-Sommers A (2006). Methamphet-amine use among young adults: health and social consequences. Addict Behav 31: 1469-1476.
115. Stern Y (2002). What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc 8: 448-460.
116. Tarter RE, Kirisci L, Habeych M, Reynolds M, Vanyukov M (2004). Neurobehavior disinhibition in childhood predisposes boys to substance use disorder by young adulthood: direct and mediated etiologic pathways. Drug Alcohol Depend 73: 121-132.
117. Tarter RE, Kirisci L, Mezzich A, Cornelius JR, Pajer K, Vanyukov M et al (2003). Neurobehavioral disinhibition in childhood predicts early age at onset of substance use disorder. Am J Psychiatry 160: 1078-1085.
118. Teuchert-Noodt G, Dawirs RR (1991). Age-related toxicity in prefrontal cortex and caudate-putamen complex of gerbils (Meriones unguiculatus) after a single dose of methampheta-mine. Neuropharmacology 30: 733-743.
119. Toomey R, Lyons MJ, Eisen SA, Xian H, Chantarujikapong S, Seidman LJ et al (2003). A twin study of the neuropsycho-logical consequences of stimulant abuse. Arch Gen Psychiatry 60: 303-310.
120. United Nations Office on Drugs and Crime (UNODC) 2011. World Drug Report (United Nations Publication, Sales No. E.11.XI.10).
121. Volkow ND, Chang L, Wang GJ, Fowler JS, Franceschi D, Sedler M et al (2001). Loss of dopamine transporters in methampheta-mine abusers recovers with protracted abstinence. J Neurosci 21: 9414-9418.
122. Vorhees CV, Skelton MR, Grace CE, Schaefer TL, Graham DL, Braun AA et al (2009). Effects of (\+)-methamphetamine on path integration and spatial learning, but not locomotor activity or acoustic startle, align with the stress hyporesponsive period in rats. Int J Dev Neurosci 27: 289-298.
123. Wang GJ, Volkow ND, Chang L, Miller E, Sedler M, Hitzemann R et al (2004). Partial recovery of brain metabolism in metham-phetamine abusers after protracted abstinence. Am J Psychiatry 161: 242-248.
124. Warner MH, Ernst J, Townes BD, Peel J, Preston M (1987). Relationships between IQ and neuropsychological measures in neuropsychiatric populations: within-laboratory and cross-cultural replications using WAIS and WAIS-R. J Clin Exp Neuropsychol 9: 545-562.
125. Weber E, Blackstone K, Iudicello JE, Morgan EE, Grant I, Moore DJ et al (2012). Neurocognitive deficits are associated with unemployment in chronic methamphetamine users. Drug Alcohol Depend 125: 146-153.
126. Weimar C, Konig IR, Kraywinkel K, Ziegler A, Diener HC (2004). Age and National Institutes of Health Stroke Scale Score within 6 hours after onset are accurate predictors of outcome after cerebral ischemia: development and external validation of prognostic models. Stroke 35: 158-162.
127. Winterer G, Goldman D (2003). Genetics of human prefrontal function. Brain Res Brain Res Rev 43: 134-163.
128. Woods SP, Rippeth JD, Conover E, Gongvatana A, Gonzalez R, Carey CL et al (2005). Deficient strategic control of verbal encoding and retrieval in individuals with methamphetamine dependence. Neuropsychology 19: 35-43.
129. Zorick T, Sugar CA, Hellemann G, Shoptaw S, London ED (2011). Poor response to sertraline in methamphetamine dependence is associated with sustained craving for methamphetamine. Drug Alcohol Depend 118: 500-503.